You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 63 No. 11, November 2006 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Article
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (91)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Neuropathology
 •Neurology, Other
 •Psychiatry
 •Depression
 •Psychiatry, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Elevated Monoamine Oxidase A Levels in the Brain

An Explanation for the Monoamine Imbalance of Major Depression

Jeffrey H. Meyer, MD, PhD; Nathalie Ginovart, PhD; Anahita Boovariwala, BSc; Sandra Sagrati, BSc; Doug Hussey, BSc; Armando Garcia, BSc; Trevor Young, MD, PhD; Nicole Praschak-Rieder, MD; Alan A. Wilson, PhD; Sylvain Houle, MD, PhD

Arch Gen Psychiatry. 2006;63:1209-1216.

Context  The monoamine theory of depression proposes that monoamine levels are lowered, but there is no explanation for how monoamine loss occurs. Monoamine oxidase A (MAO-A) is an enzyme that metabolizes monoamines, such as serotonin, norepinephrine, and dopamine.

Objective  To determine whether MAO-A levels in the brain are elevated during untreated depression.

Setting  Tertiary care psychiatric hospital.

Patients  Seventeen healthy and 17 depressed individuals with major depressive disorder that met entry criteria were recruited from the care of general practitioners and psychiatrists. All study participants were otherwise healthy and nonsmoking. Depressed individuals had been medication free for at least 5 months.

Main Outcome Measure  Harmine labeled with carbon 11, a radioligand selective for MAO-A and positron emission tomography, was used to measure MAO-A DVS(specific distribution volume), an index of MAO-A density, in different brain regions (prefrontal cortex, anterior cingulate cortex, posterior cingulate cortex, caudate, putamen, thalamus, anterior temporal cortex, midbrain, hippocampus, and parahippocampus).

Results  The MAO-A DVS was highly significantly elevated in every brain region assessed (t test; P = .001 to 3x10–7). The MAO-A DVS was elevated on average by 34% (2 SDs) throughout the brain during major depression.

Conclusions  The sizable magnitude of this finding and the absence of other compelling explanations for monoamine loss during major depressive episodes led to the conclusion that elevated MAO-A density is the primary monoamine-lowering process during major depression.


Author Affiliations: Vivian M. Rakoff PET Imaging Centre (Drs Meyer, Ginovart, Praschak-Rieder, Wilson, and Houle, Mss Boovariwala and Sagrati, and Messrs Hussey and Garcia) and Mood and Anxiety Disorders Division (Drs Meyer and Young), Clarke Division, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario; and Department of General Psychiatry, Medical University of Vienna, Vienna, Austria (Dr Praschak-Rieder).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuroleptic Malignant Syndrome Versus Serotonin Syndrome: The Search for a Diagnostic Tool
Sokoro et al.
The Annals of Pharmacotherapy 2011;45:e50-e50.
ABSTRACT | FULL TEXT  

Monoamine Oxidase A Binding in the Prefrontal and Anterior Cingulate Cortices During Acute Withdrawal From Heavy Cigarette Smoking
Bacher et al.
Arch Gen Psychiatry 2011;68:817-826.
ABSTRACT | FULL TEXT  

Serotonin Receptor Imaging: Clinically Useful?
Parsey
JNM 2010;51:1495-1498.
ABSTRACT | FULL TEXT  

Elevated Brain Monoamine Oxidase A Binding in the Early Postpartum Period
Sacher et al.
Arch Gen Psychiatry 2010;67:468-474.
ABSTRACT | FULL TEXT  

Brain Monoamine Oxidase A Binding in Major Depressive Disorder: Relationship to Selective Serotonin Reuptake Inhibitor Treatment, Recovery, and Recurrence
Meyer et al.
Arch Gen Psychiatry 2009;66:1304-1312.
ABSTRACT | FULL TEXT  

Ethical and Cultural Considerations in Delivering Psychiatric Diagnosis: Reconciling the Gap Using MDD Diagnosis Delivery in Less-Acculturated Chinese Patients
Yeung and Kam
Transcultural Psychiatry 2008;45:531-552.
ABSTRACT  

Assessing the Assessment of Brain Serotonin Turnover--Reply
Barton et al.
Arch Gen Psychiatry 2008;65:1223-1224.
FULL TEXT  

Seasonal Variation in Human Brain Serotonin Transporter Binding
Praschak-Rieder et al.
Arch Gen Psychiatry 2008;65:1072-1078.
ABSTRACT | FULL TEXT  

Brain Monoamine Oxidase A Activity Predicts Trait Aggression
Alia-Klein et al.
J. Neurosci. 2008;28:5099-5104.
ABSTRACT | FULL TEXT  

Elevated Brain Serotonin Turnover in Patients With Depression: Effect of Genotype and Therapy
Barton et al.
Arch Gen Psychiatry 2008;65:38-46.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.